VERU INC. Finance Lease, Right-of-Use Asset, after Accumulated Amortization
VERU INC. (VERU) had Finance Lease, Right-of-Use Asset, after Accumulated Amortization of $34.00 thousand as of 2020-09-30, per its 10-K filed 2020-12-10.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:FinanceLeaseRightOfUseAsset · last filed 2020-12-10
- 2020-09-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $34.00K.
- 2020-06-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $36.00K.
- 2020-03-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $39.00K.
- 2019-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $41.00K.
| Period end | Finance Lease, Right-of-Use Asset, after Accumulated Amortization |
|---|---|
| 2020-09-30 | $34.00K 10-K · filed 2020-12-10 |
| 2020-06-30 | $36.00K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $39.00K 10-Q · filed 2020-05-13 |
| 2019-12-31 | $41.00K 10-Q · filed 2020-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |